Mark J. Holdbrook - V.P., Clinical Affairs at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
V.P., Clinical Affairs
Issuer Symbol
TARS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark J. Holdbrook since 13 Mar 2025

Holdings reported by Mark J. Holdbrook for Tarsus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 7,959 $129,811 $16.31 15 Mar 2023 Direct Common Stock
Common Stock 3,191 $63,820 $20.00 20 Mar 2023 Direct

Transactions reported by Mark J. Holdbrook for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.